NCT06940635 (c-STEPS) is a NA clinical trial of closed-loop BCI-FES device in Ischaemic Stroke, sponsored by VASCage GmbH.

Who is sponsoring NCT06940635?

NCT06940635 is sponsored by VASCage GmbH.

What drugs are being tested in NCT06940635?

Interventions in NCT06940635: closed-loop BCI-FES device.

What condition does NCT06940635 study?

NCT06940635 studies Ischaemic Stroke, Hemorrhagic Stroke.

Is NCT06940635 still recruiting?

NCT06940635 is currently recruiting now. Last updated 26 November 2025.

Last reviewed 2025-11-26 · How we verify

NCT06940635: c-STEPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploratory Study on the Potential Cross-System Effects of BCI-FES Hand Therapy on Dysphagia and Aphasia in Chronic Stroke Patients

Recruiting now NA Last updated 26 November 2025

What this trial tests

NA trial testing closed-loop BCI-FES device in Ischaemic Stroke in 10 participants. Currently enrolling.

Timeline

4 June 2025

Primary endpoint
30 June 2026

30 June 2026

Quick facts

Lead sponsor	VASCage GmbH
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	4 June 2025
Primary completion	30 June 2026
Estimated completion	30 June 2026
Sites	1 location across Austria

Drugs / interventions tested

closed-loop BCI-FES device

Conditions studied

Ischaemic Stroke — all drugs for Ischaemic Stroke →
Hemorrhagic Stroke — all drugs for Hemorrhagic Stroke →

Sponsor

VASCage GmbH

Who can join

18 and older, any sex, with Ischaemic Stroke or Hemorrhagic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this neurorehabilitation explorative study is to investigate how a closed-loop Brain-Computer Interface Functional Electrical Stimulation (BCI-FES) therapy, used within the intended purpose for hand rehabilitation, may impact swallowing difficulties (dysphagia) and language disorders (aphasia) in post-stroke patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ischaemic Stroke

Currently open trials in the same condition.

NCT07197996 — The RETRAIN Trial Phase 2 · NA · recruiting
NCT06987643 — A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke · Phase 2 · recruiting
NCT05922540 — a Cohort Study of Ischemic Cerebrovascular Disease · recruiting

Other VASCage GmbH trials

Trials by the same sponsor.

NCT07511868 — Digital Application for Stroke Health · NA · not yet recruiting
NCT06813677 — Innsbruck Health Promotion Program · NA · recruiting
NCT05741827 — YOUhealTH - a Study to Improve Cardiovascular Health in Adolescents and Adults · NA · completed
NCT04749004 — A Randomized-Controlled Lifestyle Intervention to Increase Physical Activity Levels in Adolescents · NA · completed
NCT04845269 — Post-Stroke Osteopathy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06940635 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VASCage GmbH
Last refreshed: 26 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06940635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing